alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,451–6,475 of 7,816 matching trials · page 259 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
NCT01529619
Rivastigmine transdermal patch
Runs in: Japan · 11 sites 		PHASE4
symptomatic-cholinergic		 COMPLETED 52 Novartis Pharmaceuticals
INDUSTRY		 2016-11-18
Move for Your Mind - Pilot Trial
NCT02279316
Vi-De 3; Jaques-Dalcroze eurhythmics; Home exercise program
Runs in: Switzerland · 1 site 		NA
other		 COMPLETED 19 University of Zurich
OTHER		 2016-11-17
Two Anger Management Programs for Teens.
NCT02001246
Real Deal program for Anger Management; Mind-body Bridging (MBB) program
Runs in: United States · 2 sites 		NA
other		 TERMINATED 35 University of Utah
OTHER		 2016-11-15
The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms
NCT01780519
lorazepam
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 57 Mayo Clinic
OTHER		 2016-11-10
Influence of Fitness on Brain and Cognition
NCT00438347
Aerobic Exercise; Stretching and toning
Runs in: United States · 2 sites 		NA
other		 COMPLETED 179 University of Illinois at Urbana-Champaign
OTHER		 2016-11-08
Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)
NCT00688207
Rosiglitazone (Extended Release)
Runs in: Germany · 1 site 		PHASE1
other		 COMPLETED 14 GlaxoSmithKline
INDUSTRY		 2016-11-07
Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders
NCT00911690
Runs in: United States · 1 site 		NA
other		 COMPLETED 102 Corewell Health East
OTHER		 2016-11-04
Memory Encoding Strategies for People With Mild Cognitive Impairments
NCT02953964
Behavioral: perceptual-based memory encoding training; Behavioral: ...
Runs in: Australia; Hong Kong · 2 sites 		NA
other		 COMPLETED 60 University of Western Sydney
OTHER		 2016-11-03
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
NCT00531804
gantenerumab
Runs in: Denmark; Israel; Netherlands; Sweden; United Kingdom · 9 sites 		PHASE1
anti-amyloid-antibody		 COMPLETED 60 Hoffmann-La Roche
INDUSTRY		 2016-11-02
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
NCT00884507
Placebo; RO5313534; RO5313534; RO5313534
Runs in: Argentina; Australia; Canada; France; Germany; Italy; Mex... · 67 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 389 Hoffmann-La Roche
INDUSTRY		 2016-11-02
A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers
NCT01701089
11C-L-deprenyl-D2; RO4602522; RO4602522
Runs in: Sweden · 1 site 		PHASE1
other		 COMPLETED 17 Hoffmann-La Roche
INDUSTRY		 2016-11-02
Cognitive Impairment and Balance in Elderly
NCT02051270
Descriptive study
Runs in: Spain · 1 site 		NA
other		 COMPLETED 82 Universidad de Granada
OTHER		 2016-11-02
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
NCT02648906
Choline alfoscerate; Placebo
Runs in: South Korea · 1 site 		PHASE4
symptomatic-cholinergic		 UNKNOWN 128 Daewoong Pharmaceutical Co. LTD.
INDUSTRY		 2016-11-02
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
NCT00739843
Runs in: United States · 1 site 		NA
other		 TERMINATED 55 University of Chicago
OTHER		 2016-11-01
A Pre-Cellular Therapy Observational Study in Early Huntington's Disease
NCT01937923
Runs in: United States · 1 site 		NA
other		 COMPLETED 29 University of California, Davis
OTHER		 2016-11-01
Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's.
NCT01701544
NBM DBS
Runs in: United Kingdom · 1 site 		PHASE1|PHASE2
other		 COMPLETED 6 University College, London
OTHER		 2016-10-31
Deep Brain Stimulation for Patients With Dementia With Lewy Bodies
NCT02263937
Bilateral Nucleus Basalis Meynert DBS; Sham Nucleus Basalis Meynert DBS
Runs in: United Kingdom · 2 sites 		NA
other		 COMPLETED 6 University College, London
OTHER		 2016-10-31
fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
NCT00478491
Runs in: United States · 1 site 		NA
other		 COMPLETED 390 University of Wisconsin, Madison
OTHER		 2016-10-27
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491
Runs in: France; Japan · 9 sites 		NA
other		 COMPLETED 205 University Hospital, Lille
OTHER		 2016-10-27
Improving Dementia Caregiver Sleep & the Effect on Heart Disease Biomarkers
NCT01550172
Sleep Behavioral Therapy A and NHMS; Sleep Behavioral Therapy B and NHMS
Runs in: United States · 1 site 		NA
other		 COMPLETED 80 University of South Florida
OTHER		 2016-10-26
Short-term Caregiver Psychotherapy
NCT02175953
Psychotherapy
Runs in: Germany · 1 site 		PHASE2
other		 COMPLETED 13 University of Rostock
OTHER		 2016-10-26
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
NCT00120874
Individualized management of AD including caregiver training; Memantine
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 20 NYU Langone Health
OTHER		 2016-10-25
Meaningful Activity Intervention for Persons With Mild Cognitive Impairment
NCT01843283
Daily Enhancement Meaningful Activity (DEMA); Information Support (IS)
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 80 Indiana University
OTHER		 2016-10-25
MRI Brain Changes Induced by Hyperbaric Oxygen Therapy in Brain Injury Patients
NCT02452619
Hyperbaric oxygen therapy
Runs in: Israel · 2 sites 		NA
other		 UNKNOWN 30 Assaf-Harofeh Medical Center
OTHER_GOV		 2016-10-25
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
NCT00007189
Naproxen Sodium (Aleve); Celecoxib (Celebrex)
Runs in: United States · 6 sites 		PHASE3
anti-inflammatory		 COMPLETED 2,625 Seattle Institute for Biomedical and Clinical Research
OTHER		 2016-10-19

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →